Functional MR in Ischemic Cardiomyopathy
Functional MR in Ischemic Cardiomyopathy
批准号:
7497238
负责人:
Paul A Grayburn
金额:
$23.66万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2008-07-31
关键词:
Acute myocardial infarctionAddressAdverse effectsAnatomyAncillary StudyAnimal ModelAnimalsAnteriorBiometryCardiomyopathiesCicatrixClinicalClinical TrialsComplicationCoronaryCoronary Artery BypassDilated CardiomyopathyEchocardiographyEtiologyExclusionFailureGenetic screening methodHeart failureKnowledgeLaboratoriesLeftLeft Ventricular Ejection FractionLeft Ventricular RemodelingLinkMagnetic Resonance ImagingMedicalMitral Valve InsufficiencyMyocardialMyocardial InfarctionMyocardial IschemiaNumbersOperative Surgical ProceduresOutcomePatientsPrincipal InvestigatorProspective StudiesQuality of lifeRadionuclide ImagingRandomizedResearch DesignSeriesSeveritiesSymptomsTransesophageal EchocardiographyVentricularconceptdaydesignimprovedmortalityoutcome forecastprogramsrepairedresponserestorationsize
中文摘要
功能性二尖瓣反流(MR)是缺血性心脏病的常见并发症。两大临床
英文摘要
Functional mitral regurgitation (MR) is a common complication of ischemic heart disease. Two large clinical
trials confmned an adverse effect of functional MR on survival after a heart attack. However, studies in heart
failure are small and mainly limited to patients with nonischemic cardiomyopathy. Recent animal studies
have challenged the traditional concept that functional MR is a consequence of mitral annular dilation, instead
suggesting that functional MR is due to leaflet tethering by outward expansion of the left ventricular wall (i.e.
LV remodeling). This has critical implications regarding the correct surgical approach to correcting
functional MR. To date, no large prospective studies have examined the mechanism(s) of functional MR in
ischemic cardiomyopathy, nor has the interaction between mechanism and prognosis been explored. This is a
crucial knowledge gap because 1) 70% of heart failure cases are caused by ischemic heart disease, and 2)
functional MR occurs in around 60% of patients with ischemic cardiomyopathy. This proposal aims to fill
these gaps by defining the mechanism(s) of functional MR by transesophageal echocardiography in a large
clinical trial of patients with ischemic cardiomyopathy. The following specific aims will be addressed:
Aim 1: To define the mechanism(s) of functional MR in isehemie cardiomyopathy
Aim 2: To define the effect of therapy on mechanism and severity of functional MR
Aim 3: To evaluate the effect of functional MR on prognosis is ischemic cardiomyopathy
Aim 4: To evaluate the effect of myocardial viability on functional MR and its response to treatment.
We propose to accomplish these aims as an ancillary study to the Surgical Treatment for Ischemic Heart
Failure (STICH) Trial. The STICH Trial will compare surgical revaseularization versus medical therapy for
treatment of heart failure in 2800 patients with ischemic cardiomyopathy, and therefore affords a unique
opportunity to investigate the mechanism(s) of functional MR. Despite its known clinical utility for assessing
the mechanism and severity of MR, TEE is not currently included in STICH.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1089/hgtb.2013.122
发表时间:
2014-05
期刊:
Human gene therapy methods
影响因子:
--
作者:
[M. Shimoda;Shuyuan Chen;H. Noguchi;M. Takita;K. Sugimoto;T. Itoh;D. Chujo;S. Iwahashi;B. Naziruddin;M. Levy;S. Matsumoto;P. Grayburn]
通讯作者:
M. Shimoda;Shuyuan Chen;H. Noguchi;M. Takita;K. Sugimoto;T. Itoh;D. Chujo;S. Iwahashi;B. Naziruddin;M. Levy;S. Matsumoto;P. Grayburn
GENE THERAPY TO REVERSE DIABETES
-
批准号:8357703
-
项目类别:
-
资助金额:$3.07万
-
财政年份:2011
-
负责人:Paul A Grayburn
-
依托单位:
ULTRASOUND TARGETED MICROBUBBLE DESTRUCTION TO DELIVER GD MRI CONTRAST AGENTS
-
批准号:7180724
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2005
-
负责人:Paul A Grayburn
-
依托单位:
ULTRASOUND TECHNIQUE TO DELIVER GD MRI CONTRAST AGENTS
-
批准号:6977493
-
项目类别:
-
资助金额:$1.92万
-
财政年份:2004
-
负责人:Paul A Grayburn
-
依托单位:
Functional MR in Ischemic Cardiomyopathy
-
批准号:6574205
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2002
-
负责人:Paul A Grayburn
-
依托单位:
Functional MR in Ischemic Cardiomyopathy
-
批准号:6666767
-
项目类别:
-
资助金额:$34.42万
-
财政年份:2002
-
负责人:Paul A Grayburn
-
依托单位:
Functional MR in Ischemic Cardiomyopathy
-
批准号:6930425
-
项目类别:
-
资助金额:$33.82万
-
财政年份:2002
-
负责人:Paul A Grayburn
-
依托单位:
Functional MR in Ischemic Cardiomyopathy
-
批准号:6771737
-
项目类别:
-
资助金额:$10.51万
-
财政年份:2002
-
负责人:Paul A Grayburn
-
依托单位:
VENTRICULAR REMODELING IN HEART FAILURE
-
批准号:6638083
-
项目类别:
-
资助金额:$6.98万
-
财政年份:1999
-
负责人:Paul A Grayburn
-
依托单位:
VENTRICULAR REMODELING IN HEART FAILURE
-
批准号:2835621
-
项目类别:
-
资助金额:$9.07万
-
财政年份:1999
-
负责人:Paul A Grayburn
-
依托单位:
VENTRICULAR REMODELING IN HEART FAILURE
-
批准号:6683623
-
项目类别:
-
资助金额:$9.12万
-
财政年份:1999
-
负责人:Paul A Grayburn
-
依托单位:
VENTRICULAR REMODELING IN HEART FAILURE
-
批准号:6388512
-
项目类别:
-
资助金额:$9.07万
-
财政年份:1999
-
负责人:Paul A Grayburn
-
依托单位:
VENTRICULAR REMODELING IN HEART FAILURE
-
批准号:6536537
-
项目类别:
-
资助金额:$2.14万
-
财政年份:1999
-
负责人:Paul A Grayburn
-
依托单位:
VENTRICULAR REMODELING IN HEART FAILURE
-
批准号:6183571
-
项目类别:
-
资助金额:$9.07万
-
财政年份:1999
-
负责人:Paul A Grayburn
-
依托单位:
海外基金